Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Induced pluripotent stem cell technology and stem cell therapy for diabetes.

Drummond RJ, Kunath T, Mee PJ, Ross JA.

Exp Ther Med. 2011 Jan;2(1):3-7. Epub 2010 Dec 2.

2.

Endocrine regulation of energy metabolism by the skeleton.

Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G.

Cell. 2007 Aug 10;130(3):456-69.

3.

Embryonic stem cells as a source of differentiated neural cells for pharmacological screens.

Mee PJ, O'Brien CM, Thomson H, van der Sar S, Lakics V, Allsopp TE.

Methods Mol Biol. 2006;329:353-69.

PMID:
16846004
4.

Embryonic stem cells: understanding their history, cell biology and signalling.

Friel R, van der Sar S, Mee PJ.

Adv Drug Deliv Rev. 2005 Dec 12;57(13):1894-903. Epub 2005 Nov 3. Review.

PMID:
16271417
5.

G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv.

Doumont G, Martoriati A, Beekman C, Bogaerts S, Mee PJ, Bureau F, Colombo E, Alcalay M, Bellefroid E, Marchesi F, Scanziani E, Pelicci PG, Marine JC.

EMBO J. 2005 Sep 7;24(17):3093-103. Epub 2005 Aug 18.

6.

Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors.

Kawaguchi J, Mee PJ, Smith AG.

Bone. 2005 May;36(5):758-69. Epub 2005 Mar 24.

PMID:
15794925
7.

Knock-in of nuclear localised beta-galactosidase reveals that the tyrosine phosphatase Ptprv is specifically expressed in cells of the bone collar.

Dacquin R, Mee PJ, Kawaguchi J, Olmsted-Davis EA, Gallagher JA, Nichols J, Lee K, Karsenty G, Smith A.

Dev Dyn. 2004 Apr;229(4):826-34.

8.

An unpaired mouse centromere passes consistently through male meiosis and does not significantly compromise spermatogenesis.

Mee PJ, Shen MH, Smith AG, Brown WR.

Chromosoma. 2003 Dec;112(4):183-9. Epub 2003 Nov 8.

PMID:
14608464
9.

Visualization of whole-mount skeletal expression patterns of LacZ reporters using a tissue clearing protocol.

Kawaguchi J, Wilson V, Mee PJ.

Biotechniques. 2002 Jan;32(1):66, 68-70, 72-3.

10.

Artificial chromosomes: ideal vectors?

Brown WR, Mee PJ, Hong Shen M.

Trends Biotechnol. 2000 May;18(5):218-23. Review.

PMID:
10758517
11.

A structurally defined mini-chromosome vector for the mouse germ line.

Shen MH, Mee PJ, Nichols J, Yang J, Brook F, Gardner RL, Smith AG, Brown WR.

Curr Biol. 2000 Jan 13;10(1):31-4.

12.

Greatly reduced efficiency of both positive and negative selection of thymocytes in CD45 tyrosine phosphatase-deficient mice.

Mee PJ, Turner M, Basson MA, Costello PS, Zamoyska R, Tybulewicz VL.

Eur J Immunol. 1999 Sep;29(9):2923-33.

13.

Transchromosomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21.

Hernandez D, Mee PJ, Martin JE, Tybulewicz VL, Fisher EM.

Hum Mol Genet. 1999 May;8(5):923-33.

PMID:
10196383
14.

The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways.

Costello PS, Walters AE, Mee PJ, Turner M, Reynolds LF, Prisco A, Sarner N, Zamoyska R, Tybulewicz VL.

Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3035-40.

15.

Molecular requirements for lineage commitment in the thymus--antibody-mediated receptor engagements reveal a central role for lck in lineage decisions.

Basson MA, Bommhardt U, Mee PJ, Tybulewicz VL, Zamoyska R.

Immunol Rev. 1998 Oct;165:181-94. Review.

PMID:
9850861
16.

Hierarchical interactions of control elements determine CD8alpha gene expression in subsets of thymocytes and peripheral T cells.

Hostert A, Garefalaki A, Mavria G, Tolaini M, Roderick K, Norton T, Mee PJ, Tybulewicz VL, Coles M, Kioussis D.

Immunity. 1998 Oct;9(4):497-508.

17.

Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.

Connor F, Bertwistle D, Mee PJ, Ross GM, Swift S, Grigorieva E, Tybulewicz VL, Ashworth A.

Nat Genet. 1997 Dec;17(4):423-30.

PMID:
9398843
18.

A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes.

Turner M, Mee PJ, Walters AE, Quinn ME, Mellor AL, Zamoyska R, Tybulewicz VL.

Immunity. 1997 Oct;7(4):451-60.

19.

Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions.

Nishinakamura R, Miyajima A, Mee PJ, Tybulewicz VL, Murray R.

Blood. 1996 Oct 1;88(7):2458-64.

PMID:
8839836
20.

Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.

Turner M, Mee PJ, Costello PS, Williams O, Price AA, Duddy LP, Furlong MT, Geahlen RL, Tybulewicz VL.

Nature. 1995 Nov 16;378(6554):298-302.

PMID:
7477352
21.

Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav.

Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz VL.

Nature. 1995 Mar 30;374(6521):467-70.

PMID:
7700358
22.

Response of mouse skin tumors to doxorubicin is dependent on carcinogen exposure.

Keith WN, Mee PJ, Brown R.

Cancer Res. 1990 Nov 1;50(21):6841-7.

23.

Construction and hormone regulation of a novel retroviral vector.

Mee PJ, Brown R.

Gene. 1990 Apr 16;88(2):289-92.

PMID:
2161384

Supplemental Content

Support Center